Bio-Plex Biological Assay Panels

The National Heart Lung and Blood Institute, a division of the Department of Health and Human Services' National Institutes of Health, is soliciting Bio-Plex Biological Assay Panels through this procurement opportunity. This acquisition falls under NAICS code 325414 for Biological Product Manufacturing and PSC code 6505 for Drugs and Biologicals, indicating the agency seeks specialized biological testing panels used in research and diagnostic applications. The solicitation was posted on August 7, 2025, with responses due by August 15, 2025, providing potential contractors with an eight-day response window. The procurement appears focused on acquiring standardized biological assay panels that likely support the Institute's cardiovascular, pulmonary, and hematologic research missions. No specific evaluation criteria or additional qualification requirements are detailed in the available solicitation information.

This opportunity does not utilize any set-aside designations, making it open to full and open competition among all qualified contractors. The solicitation notice does not identify any incumbent contractors, potential award values, or specific quantities of biological assay panels being procured. Similarly, no timeline for service delivery or place of performance location is specified in the current documentation. The brief nature of the solicitation summary suggests that detailed technical specifications, pricing requirements, and performance parameters would be contained in the full solicitation documents available to registered contractors. Given the specialized nature of biological assay panels and the research-focused mission of the National Heart Lung and Blood Institute, this procurement likely targets established manufacturers or distributors with expertise in multiplex biological testing systems.